WARD-Home - Continuous Monitoring of Vital Parameters for Early Detection of Complications in Patients Discharged After Acute Medical Hospitalization
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Duration of data collection from the Lifetouch patch
研究概览
简要总结
The current pilot study aims to investigate the feasibility of wireless, continuous monitoring of patients in the days around discharge after an acute medical hospitalization, as well as occurrence of deviating vital signs in this patient group.
详细描述
The healthcare system is challenged by an aging patient population with chronic diseases, and acute admissions must be housed in hospitals with fewer beds and less staff resources. This increases the need for earlier discharge and for treatment shifted to the patients' own home. Furthermore, the transition from the hospital to the home setting is one of potential hazard, due to the lack of observation and intervention possibilities.
This pilot study aims to investigate the feasibility of wireless, continuous monitoring of patients in the days around discharge after an acute medical hospitalization, as well as occurrence of deviating vital signs i in the patients' own homes during the first days after discharge.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients (≥18 years) Admitted with an acute medical disease and scheduled for discharge to their own homes within five days from inclusion.
排除标准
- •Allergy to plaster, plastic, or silicone.
- •A pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
- •If the patient was deemed not able to open the front door when visited by the investigator.
- •Inability to give informed consent.
结局指标
主要结局
Duration of data collection from the Lifetouch patch
时间窗: Up to 8 days of monitoring
次要结局
- Number of events with SpO2 < 85% in at least 5 consecutive minutes(Up to 8 days of monitoring)
- Duration of complete peripheral saturation data(Up to 8 days of monitoring)
- Duration of complete blood pressure data(Up to 8 days of monitoring)
- Cummulated duration of desaturation(Up to 8 days of monitoring)
- Number of events with SpO2 < 88% in at least 10 consecutive minutes(Up to 8 days of monitoring)
- Number of deviating vital parameters in accordance to defined microevents(Up to 8 days of monitoring)
研究者
Vibeke Eriksen
Principal Investigator
Rigshospitalet, Denmark